• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医院获得性感染中艰难梭菌菌株的分子流行病学

Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections.

作者信息

Corbellini Silvia, Piccinelli Giorgio, De Francesco Maria Antonia, Ravizzola Giuseppe, Bonfanti Carlo

机构信息

Institute of Microbiology, Department of Molecular and Translational Medicine, University of Brescia, P. le Spedali Civili, 1, 25123, Brescia, Italy.

出版信息

Folia Microbiol (Praha). 2014 Mar;59(2):173-9. doi: 10.1007/s12223-013-0281-3. Epub 2013 Oct 1.

DOI:10.1007/s12223-013-0281-3
PMID:24081935
Abstract

The purpose of this study is to analyze isolates of Clostridium difficile from patients with nosocomial acquired infection in respect to their molecular type and antimicrobial susceptibility. Fifty-nine randomly selected clinical isolates were characterized. Molecular typing was performed by rep-PCR (DiversiLab). Isolates were tested by disk diffusion towards 11 different antibiotics. All isolates were susceptible to metronidazole and vancomycin. Fifty five (93 %) isolates were resistant to erythromycin and fifty six (95 %) exhibited resistance to both clindamycin and moxifloxacin. Twenty rep-PCR types were identified, but most clinical isolates formed four major rep-PCR clusters (A1 24/59, 40 %; A2 20/59, 33 %; A3 5/59, 8 %; A4 3/59, 5 %). These results show high genetic variability, which demonstrate clearly the complexity of the strains of C. difficile and also show an increasing rate of resistance to fluoroquinolones in our region emphasizing the importance of implementing surveillance programs in order to prevent further spread of resistance in C. difficile.

摘要

本研究的目的是分析医院获得性感染患者艰难梭菌分离株的分子类型和抗菌药敏性。对59株随机选择的临床分离株进行了特征分析。采用rep-PCR(DiversiLab)进行分子分型。通过纸片扩散法对分离株进行11种不同抗生素的药敏试验。所有分离株对甲硝唑和万古霉素敏感。55株(93%)分离株对红霉素耐药,56株(95%)对克林霉素和莫西沙星均耐药。鉴定出20种rep-PCR类型,但大多数临床分离株形成了四个主要的rep-PCR簇(A1 24/59,40%;A2 20/59,33%;A3 5/59,8%;A4 3/59,5%)。这些结果显示出高度的遗传变异性,清楚地表明了艰难梭菌菌株的复杂性,也显示出我们地区对氟喹诺酮类药物的耐药率在上升,强调了实施监测计划以防止艰难梭菌耐药性进一步传播的重要性。

相似文献

1
Molecular epidemiology of Clostridium difficile strains from nosocomial-acquired infections.医院获得性感染中艰难梭菌菌株的分子流行病学
Folia Microbiol (Praha). 2014 Mar;59(2):173-9. doi: 10.1007/s12223-013-0281-3. Epub 2013 Oct 1.
2
Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.全基因组测序揭示中国单中心艰难梭菌的高医院内传播和耐药性:一项四年回顾性研究。
Microbiol Spectr. 2022 Feb 23;10(1):e0132221. doi: 10.1128/spectrum.01322-21. Epub 2022 Jan 12.
3
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals.来自韩国两家医院的艰难梭菌分离株的分子流行病学及抗菌药物敏感性
PLoS One. 2017 Mar 29;12(3):e0174716. doi: 10.1371/journal.pone.0174716. eCollection 2017.
4
The molecular characters and antibiotic resistance of Clostridioides difficile from economic animals in China.中国经济动物中产艰难梭菌的分子特征及耐药性
BMC Microbiol. 2020 Mar 30;20(1):70. doi: 10.1186/s12866-020-01757-z.
5
Clinical characteristics of community-onset Clostridioides difficile infections at a tertiary hospital in mainland China: A fourteen-year (2010-2023) retrospective study.中国大陆一家三级医院社区获得性艰难梭菌感染的临床特征:一项十四年(2010-2023)回顾性研究。
Int J Med Microbiol. 2024 Sep;316:151631. doi: 10.1016/j.ijmm.2024.151631. Epub 2024 Jul 14.
6
Characteristics of Clostridium difficile isolates and the burden of hospital-acquired Clostridium difficile infection in a tertiary teaching hospital in Chongqing, Southwest China.中国西南地区重庆一家三级教学医院艰难梭菌分离株的特征和医院获得性艰难梭菌感染的负担。
BMC Infect Dis. 2020 Apr 15;20(1):277. doi: 10.1186/s12879-020-05014-6.
7
Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan.台湾地区艰难梭菌临床分离株的抗菌药敏试验结果和分子流行病学研究
Antimicrob Agents Chemother. 2011 Apr;55(4):1701-5. doi: 10.1128/AAC.01440-10. Epub 2011 Jan 24.
8
Molecular epidemiology of Clostridium difficile infection in a major chinese hospital: an underrecognized problem in Asia?艰难梭菌感染的分子流行病学研究:亚洲的一个被忽视的问题?
J Clin Microbiol. 2013 Oct;51(10):3308-13. doi: 10.1128/JCM.00587-13. Epub 2013 Jul 31.
9
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.tcdA 阴性且 tcdB 阳性的 ST81 型艰难梭菌克隆株对氟喹诺酮类药物表现出高度耐药性:来自中国北京的一项多中心研究。
Int J Antimicrob Agents. 2020 Jul;56(1):105981. doi: 10.1016/j.ijantimicag.2020.105981. Epub 2020 Apr 21.
10
Surveillance of antimicrobial susceptibilities reveals high proportions of multidrug resistance in toxigenic Clostridium difficile strains in different areas of Poland.耐药性监测显示,波兰不同地区产毒艰难梭菌菌株的多重耐药率较高。
Anaerobe. 2020 Apr;62:102167. doi: 10.1016/j.anaerobe.2020.102167. Epub 2020 Feb 13.

引用本文的文献

1
Ribotyping of Clostridioides difficile in the Liberec Regional Hospital: a tertiary health care facility.利贝雷茨地区医院艰难梭菌的核糖体分型:一家三级保健医疗机构。
Folia Microbiol (Praha). 2023 Apr;68(2):315-320. doi: 10.1007/s12223-022-01021-z. Epub 2022 Dec 1.
2
Clostridioides difficile Whole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain.艰难梭菌全基因组测序可区分同一菌株复发与新菌株再感染。
Clin Infect Dis. 2021 Mar 1;72(5):806-813. doi: 10.1093/cid/ciaa159.

本文引用的文献

1
Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.意大利城市医院的艰难梭菌感染:2006 年至 2011 年的数据。
BMC Infect Dis. 2013 Mar 22;13:146. doi: 10.1186/1471-2334-13-146.
2
Laboratory diagnosis of Clostridium difficile associated diarrhoea and molecular characterization of clinical isolates.艰难梭菌相关性腹泻的实验室诊断及临床分离株的分子特征分析
New Microbiol. 2012 Jul;35(3):307-16. Epub 2012 Jun 30.
3
Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.
韩国一家三级保健医院艰难梭菌感染的流行病学。
Clin Microbiol Infect. 2013 Jun;19(6):521-7. doi: 10.1111/j.1469-0691.2012.03910.x. Epub 2012 Jun 19.
4
Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates.艰难梭菌的药敏试验:EUCAST 流行病学折点值与纸片扩散法的相关性。
Clin Microbiol Infect. 2012 Aug;18(8):E266-72. doi: 10.1111/j.1469-0691.2012.03907.x. Epub 2012 Jun 4.
5
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009).欧洲抗菌药物消耗监测(ESAC):欧洲地区(1997-2009 年)的门诊喹诺酮类药物使用情况。
J Antimicrob Chemother. 2011 Dec;66 Suppl 6:vi47-56. doi: 10.1093/jac/dkr457.
6
Prevalence and diversity of Clostridium difficile strains in infants.婴儿艰难梭菌菌株的流行率和多样性。
J Med Microbiol. 2011 Aug;60(Pt 8):1112-1118. doi: 10.1099/jmm.0.029736-0. Epub 2011 Mar 10.
7
Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan.台湾地区艰难梭菌临床分离株的抗菌药敏试验结果和分子流行病学研究
Antimicrob Agents Chemother. 2011 Apr;55(4):1701-5. doi: 10.1128/AAC.01440-10. Epub 2011 Jan 24.
8
Clostridium difficile infection in Europe: a hospital-based survey.欧洲艰难梭菌感染:一项基于医院的调查。
Lancet. 2011 Jan 1;377(9759):63-73. doi: 10.1016/S0140-6736(10)61266-4.
9
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.人源强毒力艰难梭菌表现出更高的孢子形成能力和旺盛的毒素产生。
J Bacteriol. 2010 Oct;192(19):4904-11. doi: 10.1128/JB.00445-10. Epub 2010 Jul 30.
10
The changing epidemiology of Clostridium difficile infections.艰难梭菌感染的流行病学变化。
Clin Microbiol Rev. 2010 Jul;23(3):529-49. doi: 10.1128/CMR.00082-09.